Header Logo

Connection

Stephen Martin to Opioid-Related Disorders

Back to Details
This is a "connection" page, showing publications Stephen Martin has written about Opioid-Related Disorders.
Stephen Martin
Connection Strength
4.024
Opioid-Related Disorders
  1. Chan B, Cook R, Levander X, Wiest K, Hoffman K, Pertl K, Petluri R, McCarty D, Korthuis PT, Martin SA. Buprenorphine discontinuation in telehealth-only treatment for opioid use disorder: A longitudinal cohort analysis. J Subst Use Addict Treat. 2024 Dec; 167:209511.
    View in: PubMed
    Score: 0.532
  2. Grande LA, Cundiff D, Greenwald MK, Murray M, Wright TE, Martin SA. Evidence on Buprenorphine Dose Limits: A Review. J Addict Med. 2023 Sep-Oct 01; 17(5):509-516.
    View in: PubMed
    Score: 0.489
  3. Randall A, Hull I, Martin SA. Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation. J Addict Med. 2023 Mar-Apr 01; 17(2):237-240.
    View in: PubMed
    Score: 0.465
  4. Bosse JD, Hoffman K, Wiest K, Todd Korthuis P, Petluri R, Pertl K, Martin SA. Patient evaluation of a smartphone application for telehealth care of opioid use disorder. Addict Sci Clin Pract. 2022 09 09; 17(1):50.
    View in: PubMed
    Score: 0.464
  5. Martin SA, Chiodo LM, Wilson A. Common Misperceptions About Buprenorphine Prescribing for Opioid Use Disorder. Am Fam Physician. 2019 10 01; 100(7):396-397.
    View in: PubMed
    Score: 0.378
  6. Martin SA, Chiodo LM, Wilson A. Retention in care as a quality measure for opioid use disorder. Subst Abus. 2019; 40(4):453-458.
    View in: PubMed
    Score: 0.374
  7. Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2019 06 04; 170(11):821-822.
    View in: PubMed
    Score: 0.370
  8. Martin SA, Chiodo LM, Bosse JD, Wilson A. The Next Stage of Buprenorphine Care for Opioid Use Disorder. Ann Intern Med. 2018 11 06; 169(9):628-635.
    View in: PubMed
    Score: 0.354
  9. Mullin DJ, Cahill A, Alford DP, Bergeron N, Cushman PA, Gonzalez G, Martin SA, Peterkin AF, Pothos EN, Pulaski M, Terrien JM, Fischer MA. Impact of Asynchronous Training on Student's Confidence and Attitudes Regarding Patients With Opioid Use Disorders. Subst Use Addctn J. 2026 Jan; 47(1):171-178.
    View in: PubMed
    Score: 0.141
  10. Williams BE, Martin SA, Hoffman KA, Andrus MD, Dellabough-Gormley E, Buchheit BM. "It's within your own power": shared decision-making to support transitions to buprenorphine. Addict Sci Clin Pract. 2025 Mar 07; 20(1):22.
    View in: PubMed
    Score: 0.138
  11. Grande LA, Hutch T, Jack K, Mironov W, Iwuoha J, Muy-Rivera M, Grillo J, Martin SA, Herring A. Ketamine-assisted buprenorphine initiation: a pilot case series. Addict Sci Clin Pract. 2024 Aug 29; 19(1):60.
    View in: PubMed
    Score: 0.133
  12. Anderson JB, Martin SA, Gadomski A, Krupa N, Mullin D, Cahill A, Jenkins P. Project ECHO and primary care buprenorphine treatment for opioid use disorder: Implementation and clinical outcomes. Subst Abus. 2022; 43(1):222-230.
    View in: PubMed
    Score: 0.106
  13. Runyan CN, Hewitt AL, Martin SA, Mullin D. Confronting the new epidemic: Integrated care for opioid use disorders. Fam Syst Health. 2017 06; 35(2):248-250.
    View in: PubMed
    Score: 0.080
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.